Elisabeth Dequeker

3.8k total citations
76 papers, 1.7k citations indexed

About

Elisabeth Dequeker is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Elisabeth Dequeker has authored 76 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cancer Research, 28 papers in Pulmonary and Respiratory Medicine and 20 papers in Oncology. Recurrent topics in Elisabeth Dequeker's work include Cancer Genomics and Diagnostics (31 papers), Genomics and Rare Diseases (20 papers) and Lung Cancer Treatments and Mutations (15 papers). Elisabeth Dequeker is often cited by papers focused on Cancer Genomics and Diagnostics (31 papers), Genomics and Rare Diseases (20 papers) and Lung Cancer Treatments and Mutations (15 papers). Elisabeth Dequeker collaborates with scholars based in Belgium, Netherlands and United Kingdom. Elisabeth Dequeker's co-authors include Michael A. Morris, J. Han van Krieken, Zandra C. Deans, Nicola Normanno, Jean‐Jacques Cassiman, Ed Schuuring, Marjolijn J. L. Ligtenberg, Cleo Keppens, David Barton and Martin Schwarz and has published in prestigious journals such as Nature Genetics, Nature Biotechnology and PLoS ONE.

In The Last Decade

Elisabeth Dequeker

74 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Dequeker Belgium 23 570 524 458 404 388 76 1.7k
James V. Tricoli United States 26 553 1.0× 433 0.8× 1.1k 2.4× 327 0.8× 565 1.5× 62 2.3k
Nilsa C. Ramirez United States 20 615 1.1× 200 0.4× 802 1.8× 469 1.2× 899 2.3× 45 2.4k
Francesco Schettini Italy 22 463 0.8× 641 1.2× 493 1.1× 173 0.4× 861 2.2× 113 2.0k
Amy M. Fowler United States 22 459 0.8× 220 0.4× 327 0.7× 362 0.9× 558 1.4× 88 1.7k
Indraneel Mittra India 26 872 1.5× 338 0.6× 457 1.0× 296 0.7× 1.3k 3.3× 84 2.6k
Michael Schrauder Germany 24 982 1.7× 254 0.5× 846 1.8× 179 0.4× 745 1.9× 62 2.1k
Anne M. Noonan United States 27 360 0.6× 396 0.8× 561 1.2× 185 0.5× 1.3k 3.2× 117 2.1k
Jielin Sun United States 36 775 1.4× 1.3k 2.4× 1.2k 2.6× 930 2.3× 369 1.0× 94 3.0k
John R. Goffin Canada 24 560 1.0× 833 1.6× 765 1.7× 423 1.0× 988 2.5× 72 2.3k
Qamar J. Khan United States 23 392 0.7× 380 0.7× 301 0.7× 447 1.1× 810 2.1× 93 1.7k

Countries citing papers authored by Elisabeth Dequeker

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Dequeker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Dequeker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Dequeker more than expected).

Fields of papers citing papers by Elisabeth Dequeker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Dequeker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Dequeker. The network helps show where Elisabeth Dequeker may publish in the future.

Co-authorship network of co-authors of Elisabeth Dequeker

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Dequeker. A scholar is included among the top collaborators of Elisabeth Dequeker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Dequeker. Elisabeth Dequeker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dequeker, Elisabeth, et al.. (2024). Defining, exploring the sources and expressing post-mortem diagnostic uncertainty. Forensic Science Medicine and Pathology. 21(2). 728–735.
2.
Penault‐Llorca, Frédérique, Keith M. Kerr, Pilar Garrido, et al.. (2022). Expert opinion on NSCLC small specimen biomarker testing — Part 1: Tissue collection and management. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(3). 335–350. 29 indexed citations
3.
Dequeker, Elisabeth, Alan G. Fraser, Jacques J. M. van Dongen, et al.. (2022). Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force. HemaSphere. 6(6). e724–e724. 8 indexed citations
4.
Deans, Zandra C., Joo Wook Ahn, Isabel M. Carreira, et al.. (2022). Recommendations for reporting results of diagnostic genomic testing. European Journal of Human Genetics. 30(9). 1011–1016. 29 indexed citations
5.
Keppens, Cleo, Elke Boone, Paula Gameiro, et al.. (2021). Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(2). 365–376. 2 indexed citations
6.
Pelt, Gabi W. van, Elisabeth Dequeker, Raed Al Dieri, et al.. (2021). e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study. JMIR Formative Research. 5(3). e19408–e19408. 13 indexed citations
7.
Keppens, Cleo, Ed Schuuring, & Elisabeth Dequeker. (2020). Managing Deviating EQA Results: A Survey to Assess the Corrective and Preventive Actions of Medical Laboratories Testing for Oncological Biomarkers. Diagnostics. 10(10). 837–837. 3 indexed citations
8.
Keppens, Cleo, Jan H. von der Thüsen, Patrick Pauwels, et al.. (2020). Staining Performance of ALK and ROS1 Immunohistochemistry and Influence on Interpretation in Non–Small-Cell Lung Cancer. Journal of Molecular Diagnostics. 22(12). 1438–1452. 7 indexed citations
9.
Keppens, Cleo, Ed Schuuring, Zandra C. Deans, et al.. (2020). External Quality Assessment Schemes for Biomarker Testing in Oncology. Journal of Molecular Diagnostics. 22(6). 736–747. 8 indexed citations
10.
Keppens, Cleo, Ed Schuuring, & Elisabeth Dequeker. (2020). Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 478(5). 995–1006. 6 indexed citations
11.
Krieken, J. Han van, Gert De Hertogh, Gerald Höefler, et al.. (2019). Neoplastic cell percentage estimation in tissue samples for molecular oncology: recommendations from a modified Delphi study. Histopathology. 75(3). 312–319. 16 indexed citations
12.
Keppens, Cleo, et al.. (2019). Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?. Human Mutation. 41(1). 7–16. 1 indexed citations
13.
Hertogh, Gert De, et al.. (2018). External Quality Assessment Identifies Training Needs to Determine the Neoplastic Cell Content for Biomarker Testing. Journal of Molecular Diagnostics. 20(4). 455–464. 14 indexed citations
14.
Spans, Lien, Ed Schuuring, Cleo Keppens, et al.. (2018). Describing the Reportable Range Is Important for Reliable Treatment Decisions. Journal of Molecular Diagnostics. 20(6). 743–753. 9 indexed citations
15.
Keppens, Cleo, Partha Das, John F. Palma, et al.. (2016). Inter-Laboratory Comparison of the Roche Cobas EGFR Mutation Test v2 in Plasma. Journal of Thoracic Oncology. 12(1). 1 indexed citations
16.
Cree, Ian A., Zandra C. Deans, Marjolijn J. L. Ligtenberg, et al.. (2014). Guidance for laboratories performing molecular pathology for cancer patients. Journal of Clinical Pathology. 67(11). 923–931. 154 indexed citations
17.
Bejjani, Bassem A., et al.. (2011). Multiallelic Synthetic Quality Control Material: Lessons Learned from the Cystic Fibrosis External Quality Assessment Scheme. Genetic Testing and Molecular Biomarkers. 15(9). 579–586. 1 indexed citations
18.
Mattocks, C., Michael A. Morris, Gert Matthijs, et al.. (2010). A standardized framework for the validation and verification of clinical molecular genetic tests. European Journal of Human Genetics. 18(12). 1276–1288. 141 indexed citations
19.
Dequeker, Elisabeth, E. Girodon, M. Roy Schwarz, et al.. (2004). Quality evaluation of data interpretation and reporting. Genetics in Medicine. 350–350. 1 indexed citations
20.
Matthijs, Gert, Elisabeth Dequeker, Els Schollen, et al.. (2003). Quality assurance of novel diagnostic technologies: a collaborative effort towards the generation of "generic SOPs" for DHPLC analysis. The American Journal of Human Genetics. 73(5). 414–414. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James V. Tricoli Breakdown of academic impact, for papers by Nilsa C. Ramirez Breakdown of academic impact, for papers by Francesco Schettini Breakdown of academic impact, for papers by Amy M. Fowler Breakdown of academic impact, for papers by Indraneel Mittra Breakdown of academic impact, for papers by Michael Schrauder Breakdown of academic impact, for papers by Anne M. Noonan Breakdown of academic impact, for papers by Jielin Sun Breakdown of academic impact, for papers by John R. Goffin Breakdown of academic impact, for papers by Qamar J. Khan
Rankless by CCL
2026